Natera provides cell-free DNA and genetic testing for prenatal screening, oncology minimal-residual-disease monitoring, and organ-transplant health.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 42 | New buy | 60 | $24,799 | 0.0% |
| Bridgewater | 55 | Added +334% | 26,640 | $11,010,578 | 0.0% |
| Stanley Druckenmiller / Duquesne | 91 | Trimmed -1% | 3,160,666 | $1,306,335 | 29.2% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -38% | 105,469 | $43,591,392 | 0.1% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-08-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.